Skip to main content

Metastatic Pancreatic Ductal Adenocarcinoma clinical trials at UCSD
1 in progress, 0 open to new patients

  • Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

    Sorry, not currently recruiting here

    This is a Phase 1, open label, multi center, multiple dose, dose escalation, safety, pharmacokinetic and pharmacodynamic study of palbociclib in combination with nab-P, in sequential cohorts of adult patients with mPDAC, with MTD expansion cohort(s). Approximately 30-60 patients are expected to be enrolled in the overall study.

    Encinitas, California and other locations

Last updated: